etoposide has been researched along with HIV in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fazal, F; Gupta, N; Mittal, A; Ray, A | 1 |
| Aboulafia, D; Ambinder, RF; Cesarman, E; Henry, D; Lee, J; Looney, D; Maldarelli, F; Mitsuyasu, R; Noy, A; Ramos, JC; Reid, EG; Sparano, J; Wachsman, W; Yahyaei, S | 1 |
| Barta, SK; Boue, F; Dunleavy, K; Galicier, L; Garcia, O; Kaplan, LD; Lee, JY; Little, RF; Morgades, M; Mounier, N; Navarro, JT; Noy, A; Oriol, A; Ratner, L; Remick, SC; Ribera, JM; Sparano, JA; Spina, M; Tamari, R; Tirelli, U; Wang, D; Weiss, R; Wilson, WH; Wyen, C; Xue, X | 1 |
| Aboulafia, D; Ambinder, RF; Cesarman, E; Chadburn, A; Dezube, BJ; Henry, DH; Kaplan, LD; Lee, JY; Leichman, L; Levine, AM; Mitsuyasu, R; Noy, A; Ramos, JC; Ratner, L; Remick, SC; Shah, MH; Sparano, JA; Von Roenn, J; Wachsman, W | 1 |
| Carrasquillo, JA; Dunleavy, K; Grant, N; Jaffe, ES; Little, RF; Pittaluga, S; Steinberg, SM; Wayne, AS; Wilson, WH; Yarchoan, R | 1 |
| Berry, C; Bushman, F; Chiang, CY; Mitchell, R | 1 |
| Bushman, F; Groschel, B | 1 |
| Becker, N; Leaf, A; Sparano, JA; Strack, M; Valentine, ES; Wiernik, PH | 1 |
| Dutcher, JP; Henry, DH; Hu, X; Mason, B; Ratech, H; Sarta, C; Schwartz, EL; Soeiro, R; Sparano, JA; Wiernik, PH | 1 |
| Cadeo, G; Carosi, G; Casari, S; Donisi, A; Re, A; Rossi, G; Stellini, R | 1 |
| Fasan, M; Gabarre, J; Spina, M; Tirelli, U; Vaccher, E | 1 |
| Church, JA; Lieberman, E; Malekzadeh, MH; Mitchell, WG; Opas, L; Siegel, SE | 1 |
2 review(s) available for etoposide and HIV
| Article | Year |
|---|---|
Haemophagocytic lymphohistiocytosis in human immunodeficiency virus: a systematic review of literature.
Topics: Adult; Anti-Retroviral Agents; Etoposide; Female; HIV; HIV Infections; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Neoplasms; Opportunistic Infections; Retrospective Studies; Steroids; Topoisomerase II Inhibitors | 2020 |
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.
Topics: Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; HIV; HIV Infections; Humans; Infusions, Intravenous; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2013 |
5 trial(s) available for etoposide and HIV
| Article | Year |
|---|---|
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; APOBEC-3G Deaminase; Bortezomib; Carboplatin; Etoposide; Female; HIV; HIV Infections; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma; Male; Middle Aged; Oncolytic Virotherapy; Recurrence; Rituximab; Viral Load | 2018 |
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2010 |
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Child; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; HIV; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Viral Load; Young Adult | 2010 |
Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; HIV; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recombinant Proteins; Retrospective Studies; Treatment Outcome; Vincristine | 1998 |
Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Etoposide; Female; HIV; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Mechlorethamine; Middle Aged; Prednisone; Vinblastine; Vincristine | 2000 |
5 other study(ies) available for etoposide and HIV
| Article | Year |
|---|---|
Global analysis of cellular transcription following infection with an HIV-based vector.
Topics: B-Lymphocytes; Etoposide; Gene Expression Profiling; Gene Transfer Techniques; Genetic Vectors; HIV; Humans; Nucleic Acid Synthesis Inhibitors; Oligonucleotide Array Sequence Analysis; Phylogeny | 2003 |
Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus.
Topics: Aphidicolin; Camptothecin; Cell Cycle; Cell Division; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; G2 Phase; HIV; HIV Infections; Humans; Nucleic Acid Synthesis Inhibitors; Paclitaxel; Time Factors; Transduction, Genetic; Virus Replication | 2005 |
Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV; HIV Infections; HIV Seropositivity; HTLV-I Infections; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Analysis; Time Factors | 1993 |
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; Didanosine; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; HIV; HIV Core Protein p24; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Survival Rate; Viremia | 1996 |
Human immunodeficiency virus-associated Kaposi's sarcoma in a pediatric renal transplant recipient.
Topics: Blood Transfusion; Child; Etoposide; HIV; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Sarcoma, Kaposi | 1987 |